Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 384

1.

Fast and accurate vision-based stereo reconstruction and motion estimation for image-guided liver surgery.

Speers AD, Ma B, Jarnagin WR, Himidan S, Simpson AL, Wildes RP.

Healthc Technol Lett. 2018 Oct 19;5(5):208-214. doi: 10.1049/htl.2018.5071. eCollection 2018 Oct.

2.

Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.

Narayan RR, Creasy JM, Goldman DA, Gönen M, Kandoth C, Kundra R, Solit DB, Askan G, Klimstra DS, Basturk O, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Kingham TP, Simpson AL, Abou-Alfa GK, Harding JJ, O'Reilly EM, Butte JM, Matsuyama R, Endo I, Jarnagin WR.

Cancer. 2018 Nov 14. doi: 10.1002/cncr.31850. [Epub ahead of print]

PMID:
30427539
3.

Laparoscopic Liver Resection Difficulty Score-a Validation Study.

Lee SY, Goh BKP, Sepideh G, Allen JC, Merkow RP, Teo JY, Chandra D, Koh YX, Tan EK, Kam JH, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF, D'Angelica MI, Jarnagin WR, Peter Kingham T, Chan CY.

J Gastrointest Surg. 2018 Nov 12. doi: 10.1007/s11605-018-4036-y. [Epub ahead of print]

PMID:
30421119
4.

Outcomes after Pancreatectomy with Routine Pasireotide Usage.

Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2018 Nov 7. pii: S1072-7515(18)32141-0. doi: 10.1016/j.jamcollsurg.2018.10.018. [Epub ahead of print]

PMID:
30414453
5.

Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2018 Nov 7. doi: 10.1007/s00268-018-4845-x. [Epub ahead of print]

PMID:
30406321
6.

Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies.

Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, Ly M, Shia J, Hechtman JF, Kundra R, El Dika I, Do RK, Sun Y, Kingham TP, D'Angelica MI, Berger MF, Hyman DM, Jarnagin WR, Klimstra DS, Janjigian YY, Solit DB, Schultz N, Abou-Alfa GK.

Clin Cancer Res. 2018 Oct 29. pii: clincanres.2293.2018. doi: 10.1158/1078-0432.CCR-18-2293. [Epub ahead of print]

PMID:
30373752
7.

Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection.

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Covey AM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Gerdes H, Allen PJ, Schattner MA.

HPB (Oxford). 2018 Oct 4. pii: S1365-182X(18)33940-6. doi: 10.1016/j.hpb.2018.08.010. [Epub ahead of print]

PMID:
30293867
8.

A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma.

Gaspersz MP, Buettner S, Roos E, van Vugt JLA, Coelen RJS, Vugts J, Wiggers JK, Allen PJ, Besselink MG, Busch ORC, Belt EJ, D'Angelica MI, DeMatteo RP, de Jonge J, Kingham TP, Polak WG, Willemssen FEJA, van Gulik TM, Jarnagin WR, Ijzermans JNM, Groot Koerkamp B.

J Surg Oncol. 2018 Sep;118(3):469-476. doi: 10.1002/jso.25174. Epub 2018 Aug 21.

PMID:
30132904
9.

Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.

Attiyeh MA, Chakraborty J, Gazit L, Langdon-Embry L, Gonen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Do RK, Simpson AL.

HPB (Oxford). 2018 Aug 7. pii: S1365-182X(18)32703-5. doi: 10.1016/j.hpb.2018.07.016. [Epub ahead of print]

PMID:
30097414
10.

A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers.

Olthof PB, Miyasaka M, Koerkamp BG, Wiggers JK, Jarnagin WR, Noji T, Hirano S, van Gulik TM.

HPB (Oxford). 2018 Aug 4. pii: S1365-182X(18)32701-1. doi: 10.1016/j.hpb.2018.07.014. [Epub ahead of print]

PMID:
30087051
11.

A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection.

Tufts LS, Jarnagin ED, Flynn JR, Gonen M, Guillem JG, Paty PB, Nash GM, Smith JJ, Wei IH, Pappou E, D'Angelica MI, Allen PJ, Peter Kingham T, Balachandran VP, Drebin JA, Garcia-Aguilar J, Jarnagin WR, Weiser MR.

HPB (Oxford). 2018 Aug 1. pii: S1365-182X(18)32686-8. doi: 10.1016/j.hpb.2018.07.001. [Epub ahead of print]

PMID:
30077525
12.

Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.

Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Ventura A.

PLoS One. 2018 Jul 27;13(7):e0200776. doi: 10.1371/journal.pone.0200776. eCollection 2018.

13.

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center.

Lidsky ME, Jarnagin WR.

Ann Gastroenterol Surg. 2018 Jun 29;2(4):304-312. doi: 10.1002/ags3.12181. eCollection 2018 Jul. Review.

14.

Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.

Gagnière J, Dupré A, Gholami SS, Pezet D, Boerner T, Gönen M, Kingham TP, Allen PJ, Balachandran VP, De Matteo RP, Drebin JA, Yaeger R, Kemeny NE, Jarnagin WR, D'Angelica MI.

Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002968. [Epub ahead of print]

PMID:
29995686
15.

"Response to Letter to the Editor: Impact of Recurrence Surveillance on Recurrence Patterns After Resection of Hepatocellular Carcinoma".

Zheng J, Chapman WC, Turcotte S, Koerkamp BG, Lee SY, Jarnagin WR.

Ann Surg. 2018 Jun 28. doi: 10.1097/SLA.0000000000002871. [Epub ahead of print] No abstract available.

PMID:
29958228
16.

Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2018 Jun 28. doi: 10.1007/s00268-018-4726-3. [Epub ahead of print] Erratum in: World J Surg. 2018 Nov 7;:.

PMID:
29955938
17.

Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.

Creasy JM, Midya A, Chakraborty J, Adams LB, Gomes C, Gonen M, Seastedt KP, Sutton EJ, Cercek A, Kemeny NE, Shia J, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI, Do RKG, Simpson AL.

Eur Radiol. 2018 Jun 19. doi: 10.1007/s00330-018-5542-8. [Epub ahead of print]

PMID:
29922934
18.

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

Lowery MA, Ptashkin R, Jordan E, Berger MF, Zehir A, Capanu M, Kemeny NE, O'Reilly EM, El-Dika I, Jarnagin WR, Harding JJ, D'Angelica MI, Cercek A, Hechtman JF, Solit DB, Schultz N, Hyman DM, Klimstra DS, Saltz LB, Abou-Alfa GK.

Clin Cancer Res. 2018 Sep 1;24(17):4154-4161. doi: 10.1158/1078-0432.CCR-18-0078. Epub 2018 May 30.

PMID:
29848569
19.

Surgery for perihilar cholangiocarcinoma.

Groot Koerkamp B, Jarnagin WR.

Br J Surg. 2018 Jun;105(7):771-772. doi: 10.1002/bjs.10875. No abstract available.

PMID:
29756647
20.

Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging.

Perrin T, Midya A, Yamashita R, Chakraborty J, Saidon T, Jarnagin WR, Gonen M, Simpson AL, Do RKG.

Abdom Radiol (NY). 2018 Dec;43(12):3271-3278. doi: 10.1007/s00261-018-1600-6.

PMID:
29730738
21.

Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.

Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, Deshwar A, Buettner S, Allen PJ, Kingham TP, Pawlik TM, He J, Cameron JL, Jarnagin WR, Wolfgang CL, D'Angelica MI, Weiss MJ.

Br J Surg. 2018 Aug;105(9):1210-1220. doi: 10.1002/bjs.10838. Epub 2018 Apr 25.

PMID:
29691844
22.

Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging.

Wiggers JK, Groot Koerkamp B, van Klaveren D, Coelen RJ, Nio CY, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Gulik TM, Jarnagin WR.

J Am Coll Surg. 2018 Aug;227(2):238-246.e2. doi: 10.1016/j.jamcollsurg.2018.03.041. Epub 2018 Apr 6.

PMID:
29627334
23.

Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN).

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Basturk O, Klimstra D, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Allen PJ.

Ann Surg Oncol. 2018 Jun;25(6):1752-1759. doi: 10.1245/s10434-018-6445-2. Epub 2018 Mar 27.

PMID:
29589164
24.

Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?

Aherne EA, Pak LM, Goldman DA, Gonen M, Jarnagin WR, Simpson AL, Do RK.

Abdom Radiol (NY). 2018 Oct;43(10):2665-2672. doi: 10.1007/s00261-018-1505-4.

PMID:
29492607
25.

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Balachandran VP, Kingham TP, DeMatteo RP, Allen PJ, Blumgart LH, Jarnagin WR, D'Angelica MI.

Surgery. 2018 Jun;163(6):1238-1244. doi: 10.1016/j.surg.2018.01.004. Epub 2018 Feb 15.

PMID:
29455841
26.

Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.

Attiyeh MA, Chakraborty J, Doussot A, Langdon-Embry L, Mainarich S, Gönen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Simpson AL, Do RK.

Ann Surg Oncol. 2018 Apr;25(4):1034-1042. doi: 10.1245/s10434-017-6323-3. Epub 2018 Jan 29.

PMID:
29380093
27.

Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.

Zheng J, Hernandez JM, Doussot A, Bojmar L, Zambirinis CP, Costa-Silva B, van Beek EJAH, Mark MT, Molina H, Askan G, Basturk O, Gonen M, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Lyden D, Jarnagin WR.

HPB (Oxford). 2018 Jul;20(7):597-604. doi: 10.1016/j.hpb.2017.12.010. Epub 2018 Jan 12.

PMID:
29339034
28.

Characterization and correction of intraoperative soft tissue deformation in image-guided laparoscopic liver surgery.

Heiselman JS, Clements LW, Collins JA, Weis JA, Simpson AL, Geevarghese SK, Kingham TP, Jarnagin WR, Miga MI.

J Med Imaging (Bellingham). 2018 Apr;5(2):021203. doi: 10.1117/1.JMI.5.2.021203. Epub 2017 Dec 14.

PMID:
29285519
29.

The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Saltz LB, Balachandran VP, Peter Kingham T, DeMatteo RP, Allen PJ, Jarnagin WR, D'Angelica MI.

Ann Surg Oncol. 2018 Feb;25(2):431-438. doi: 10.1245/s10434-017-6264-x. Epub 2017 Nov 27.

PMID:
29181680
30.

Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma?

Pak LM, Gonen M, Seier K, Balachandran VP, D'Angelica MI, Jarnagin WR, Kingham TP, Allen PJ, Do RKG, Simpson AL.

Abdom Radiol (NY). 2018 Aug;43(8):2113-2118. doi: 10.1007/s00261-017-1407-x.

PMID:
29177926
31.

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI.

J Surg Oncol. 2018 Mar;117(4):634-643. doi: 10.1002/jso.24898. Epub 2017 Nov 22.

PMID:
29165816
32.

Port-Site Resection in the Surgical Management of Incidental Gallbladder Cancer: A Still Inconclusive Question: A Reply.

Maker AV, Jarnagin WR.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):647-648. doi: 10.1245/s10434-017-6227-2. Epub 2017 Nov 7. No abstract available.

PMID:
29116487
33.

The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.

Pak LM, Schattner MA, Balachandran V, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ.

HPB (Oxford). 2018 Feb;20(2):182-187. doi: 10.1016/j.hpb.2017.09.001. Epub 2017 Oct 9.

PMID:
29033025
34.

Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis.

Zheng J, Chakraborty J, Chapman WC, Gerst S, Gonen M, Pak LM, Jarnagin WR, DeMatteo RP, Do RKG, Simpson AL; Hepatopancreatobiliary Service in the Department of Surgery of the Memorial Sloan Kettering Cancer Center; Research Staff in the Department of Surgery at Washington University School of Medicine.

J Am Coll Surg. 2017 Dec;225(6):778-788.e1. doi: 10.1016/j.jamcollsurg.2017.09.003. Epub 2017 Sep 21.

35.

3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial.

Kingham TP, Pak LM, Simpson AL, Leung U, Doussot A, D'Angelica MI, DeMatteo RP, Allen PJ, Jarnagin WR.

HPB (Oxford). 2018 Mar;20(3):260-267. doi: 10.1016/j.hpb.2017.08.035. Epub 2017 Sep 19.

PMID:
28935452
36.

Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.

Zheng J, Seier K, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Allen PJ, Jarnagin WR, DeMatteo RP.

Ann Surg Oncol. 2017 Nov;24(12):3706-3714. doi: 10.1245/s10434-017-6060-7. Epub 2017 Aug 24.

PMID:
28840521
37.

Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.

Horvat N, Nikolovski I, Long N, Gerst S, Zheng J, Pak LM, Simpson A, Zheng J, Capanu M, Jarnagin WR, Mannelli L, Do RKG.

Abdom Radiol (NY). 2018 Jan;43(1):169-178. doi: 10.1007/s00261-017-1261-x.

PMID:
28765978
38.

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype.

Lowery MA, Jordan EJ, Basturk O, Ptashkin RN, Zehir A, Berger MF, Leach T, Herbst B, Askan G, Maynard H, Glassman D, Covington C, Schultz N, Abou-Alfa GK, Harding JJ, Klimstra DS, Hechtman JF, Hyman DM, Allen PJ, Jarnagin WR, Balachandran VP, Varghese AM, Schattner MA, Yu KH, Saltz LB, Solit DB, Iacobuzio-Donahue CA, Leach SD, O'Reilly EM.

Clin Cancer Res. 2017 Oct 15;23(20):6094-6100. doi: 10.1158/1078-0432.CCR-17-0899. Epub 2017 Jul 28.

39.

Deformation correction for image guided liver surgery: An intraoperative fidelity assessment.

Clements LW, Collins JA, Weis JA, Simpson AL, Kingham TP, Jarnagin WR, Miga MI.

Surgery. 2017 Sep;162(3):537-547. doi: 10.1016/j.surg.2017.04.020. Epub 2017 Jul 10.

40.

Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ.

Ann Surg. 2018 Aug;268(2):340-347. doi: 10.1097/SLA.0000000000002421.

PMID:
28700444
41.

Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase.

Zheng J, Glezerman IG, Sadot E, McNeil A, Zarama C, Gönen M, Creasy J, Pak LM, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Jarnagin WR, Jaimes EA.

J Am Coll Surg. 2017 Oct;225(4):488-497.e2. doi: 10.1016/j.jamcollsurg.2017.06.012. Epub 2017 Jul 6.

42.

Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.

Olthof PB, Wiggers JK, Groot Koerkamp B, Coelen RJ, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Lienden KP, Jarnagin WR, van Gulik TM.

J Am Coll Surg. 2017 Sep;225(3):387-394. doi: 10.1016/j.jamcollsurg.2017.06.007. Epub 2017 Jul 4. Erratum in: J Am Coll Surg. 2018 May;226(5):945.

PMID:
28687509
43.

Should Patients With Cystic Lesions of the Pancreas Undergo Long-term Radiographic Surveillance?: Results of 3024 Patients Evaluated at a Single Institution.

Lawrence SA, Attiyeh MA, Seier K, Gönen M, Schattner M, Haviland DL, Balachandran VP, Kingham TP, D'Angelica MI, DeMatteo RP, Brennan MF, Jarnagin WR, Allen PJ.

Ann Surg. 2017 Sep;266(3):536-544. doi: 10.1097/SLA.0000000000002371.

PMID:
28657939
44.

Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.

Zheng J, Chou JF, Gönen M, Vachharajani N, Chapman WC, Majella Doyle MB, Turcotte S, Vandenbroucke-Menu F, Lapointe R, Buettner S, Groot Koerkamp B, Ijzermans JNM, Chan CY, Goh BKP, Teo JY, Kam JH, Jeyaraj PR, Cheow PC, Chung AYF, Chow PKH, Ooi LLPJ, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Lee SY.

Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360.

PMID:
28650354
45.

Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.

Simpson AL, Doussot A, Creasy JM, Adams LB, Allen PJ, DeMatteo RP, Gönen M, Kemeny NE, Kingham TP, Shia J, Jarnagin WR, Do RKG, D'Angelica MI.

Ann Surg Oncol. 2017 Sep;24(9):2482-2490. doi: 10.1245/s10434-017-5896-1. Epub 2017 May 30.

46.

Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas.

Pak LM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran VP, Jarnagin WR, Allen PJ.

J Gastrointest Surg. 2017 Oct;21(10):1599-1605. doi: 10.1007/s11605-016-3338-1. Epub 2017 May 17.

47.

Recurrence patterns following irreversible electroporation for hepatic malignancies.

Langan RC, Goldman DA, D'Angelica MI, DeMatteo RP, Allen PJ, Balachandran VP, Jarnagin WR, Kingham TP.

J Surg Oncol. 2017 May;115(6):704-710. doi: 10.1002/jso.24570. Epub 2017 May 11.

48.

Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies.

Creasy JM, Goldman DA, Gonen M, Dudeja V, Askan G, Basturk O, Balachandran VP, Allen PJ, DeMatteo RP, D'Angelica MI, Jarnagin WR, Peter Kingham T.

J Gastrointest Surg. 2017 Aug;21(8):1254-1261. doi: 10.1007/s11605-017-3436-8. Epub 2017 May 8.

49.

Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.

Groot Koerkamp B, Sadot E, Kemeny NE, Gönen M, Leal JN, Allen PJ, Cercek A, DeMatteo RP, Kingham TP, Jarnagin WR, D'Angelica MI.

J Clin Oncol. 2017 Jun 10;35(17):1938-1944. doi: 10.1200/JCO.2016.71.8346. Epub 2017 Apr 20.

50.

Levels of Evidence in Medical Research: "Bigger Is Not Always Better".

Allen PJ, D'Angelica MI, Kingham TP, Balachandran VK, Jarnagin WR.

Ann Surg. 2018 May;267(5):e96-e97. doi: 10.1097/SLA.0000000000002227. No abstract available.

PMID:
28403003

Supplemental Content

Loading ...
Support Center